News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
138,986 Results
Type
Article (8340)
Company Profile (64)
Press Release (130582)
Section
Business (41744)
Career Advice (159)
Deals (6519)
Drug Delivery (9)
Drug Development (27813)
Employer Resources (18)
FDA (3803)
Job Trends (4022)
News (77956)
Policy (5611)
Tag
Academia (429)
Alliances (11923)
Alzheimer's disease (226)
Antibody-drug conjugate (ADC) (56)
Approvals (3798)
Artificial intelligence (44)
Bankruptcy (60)
Best Places to Work (3701)
Biotechnology (57)
Breast cancer (87)
Cancer (780)
Cardiovascular disease (26)
Career advice (132)
CAR-T (44)
Cell therapy (99)
Clinical research (22851)
Collaboration (160)
Compensation (44)
COVID-19 (377)
C-suite (40)
Data (460)
Diagnostics (1491)
Drug discovery (24)
Earnings (14214)
Events (24951)
Executive appointments (118)
FDA (3972)
Funding (81)
Gene therapy (35)
GLP-1 (111)
Government (667)
Healthcare (4624)
Infectious disease (392)
Inflammatory bowel disease (24)
Interviews (26)
IPO (3224)
Job creations (510)
Job search strategy (117)
Layoffs (115)
Legal (563)
Liver cancer (37)
Lung cancer (144)
Lymphoma (28)
Manufacturing (26)
Medical device (1251)
Medtech (1252)
Mergers & acquisitions (3317)
Metabolic disorders (53)
Neuroscience (280)
NextGen Class of 2024 (1135)
Non-profit (663)
Northern California (498)
Obesity (28)
Opinion (33)
Ovarian cancer (31)
Pancreatic cancer (24)
People (13631)
Phase I (8022)
Phase II (9719)
Phase III (7466)
Pipeline (186)
Postmarket research (733)
Preclinical (2529)
Prostate cancer (36)
Radiopharmaceuticals (156)
Rare diseases (34)
Real estate (786)
Regulatory (4718)
Research institute (731)
Southern California (419)
Startups (802)
United States (3724)
Vaccines (100)
Date
Today (49)
Last 7 days (276)
Last 30 days (1156)
Last 365 days (10992)
2024 (10022)
2023 (12187)
2022 (14775)
2021 (15090)
2020 (12732)
2019 (10111)
2018 (7400)
2017 (8024)
2016 (7026)
2015 (7956)
2014 (5212)
2013 (3569)
2012 (3839)
2011 (3816)
2010 (3518)
Location
Africa (95)
Asia (11109)
Australia (1498)
California (1011)
Canada (287)
China (125)
Colorado (38)
Connecticut (42)
Delaware (45)
Europe (21377)
Florida (139)
Illinois (85)
Indiana (33)
Japan (30)
Maryland (160)
Massachusetts (861)
Minnesota (54)
New Jersey (248)
New York (273)
North Carolina (162)
Northern California (498)
Ohio (33)
Pennsylvania (197)
South America (136)
Southern California (419)
Texas (132)
Washington State (100)
138,986 Results for "elevation oncology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Elevation Oncology to Present at the Citizens JMP Life Sciences Conference 2024
Elevation Oncology, Inc. announced that Joseph J. Ferra, Chief Executive Officer of Elevation Oncology, will participate in a fireside chat at the Citizens JMP Life Sciences Conference on Tuesday, May 14, 2024, at 11:30 am ET.
May 7, 2024
·
1 min read
Drug Development
Elevation Oncology Announces Planned Combination Strategy for EO-3021 in Patients with Gastric or Gastroesophageal Junction Cancer
Elevation Oncology, Inc. announced plans to expand its ongoing Phase 1 clinical trial to include two combination cohorts evaluating EO-3021 for the treatment of advanced gastric or gastroesophageal junction cancer.
June 27, 2024
·
8 min read
Genetown
Elevation Oncology to Participate in Upcoming Investor Conferences
Elevation Oncology, Inc. today announced that members of management will participate in upcoming investor conferences in March.
February 28, 2024
·
1 min read
Business
Elevation Oncology Reports First Quarter 2024 Financial Results and Highlights Recent Business Achievements
Elevation Oncology, Inc. today announced financial results for the quarter ended March 31, 2024, and highlighted recent business achievements.
May 2, 2024
·
8 min read
Drug Development
Elevation Oncology Presents Preclinical Proof-of-Concept Data for HER3-ADC Program at AACR Annual Meeting 2024
Elevation Oncology, Inc. (Nasdaq: ELEV) today announced new preclinical data demonstrating proof-of-concept for its differentiated HER3-ADC program.
April 8, 2024
·
5 min read
Genetown
Elevation Oncology Announces Program Updates and Upcoming 2024 Milestones
Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs, today announced program updates and upcoming 2024 milestones.
January 5, 2024
·
7 min read
Business
Elevation Oncology Announces Appointment of Darcy Mootz, Ph.D., to its Board of Directors
Elevation Oncology, Inc. today announced the appointment of Darcy Mootz, Ph.D., to its Board of Directors.
January 22, 2024
·
5 min read
Business
Elevation Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business Achievements
Elevation Oncology, Inc. today announced financial results for the quarter and full-year ended December 31, 2023, and highlighted recent business achievements.
March 6, 2024
·
10 min read
Business
Elevation Oncology Appoints Experienced Clinical Development Leaders Julie Cherrington, Ph.D. and Alan Sandler, M.D. to Board of Directors
Elevation Oncology, Inc. announced the appointments of Julie Cherrington, Ph.D. and Alan Sandler, M.D., to its Board of Directors.
March 4, 2024
·
6 min read
Genetown
Elevation Oncology to Present at the Piper Sandler 35th Annual Healthcare Conference
Elevation Oncology, Inc. today announced that Joseph J. Ferra , Chief Executive Officer of Elevation Oncology, will participate in a fireside chat at the Piper Sandler 35th Annual Healthcare Conference on Wednesday, November 29, 2023, at 8:30 am ET.
November 22, 2023
·
1 min read
1 of 13,899
Next
